Immunology
-
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
This article has 19 authors:Reviewed by ScreenIT
-
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model
This article has 30 authors:Reviewed by ScreenIT
-
Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients
This article has 23 authors:Reviewed by ScreenIT
-
Development of a vaccine against the newly emerging COVID-19 virus based on the receptor binding domain displayed on virus-like particles
This article has 15 authors:Reviewed by ScreenIT
-
Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19
This article has 1 author:Reviewed by ScreenIT
-
Computational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic tool
This article has 2 authors:Reviewed by ScreenIT
-
Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection
This article has 10 authors:Reviewed by ScreenIT
-
Estimating cumulative incidence of SARS-CoV-2 with imperfect serological tests: exploiting cutoff-free approaches
This article has 4 authors:Reviewed by ScreenIT
-
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance
This article has 18 authors:Reviewed by ScreenIT
-
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates
This article has 24 authors:Reviewed by ScreenIT